Outcomes of Gleason Score ≤ 8 among high risk prostate cancer treated with 125I low dose rate brachytherapy based multimodal therapy.

about

Prostate cancer in East Asia: evolving trend over the last decade.

P2860

Q34927940-BC28224B-8B3B-46A1-A145-7C7A0681C86E

P2860

Outcomes of Gleason Score ≤ 8 among high risk prostate cancer treated with 125I low dose rate brachytherapy based multimodal therapy.

Item

http://www.wikidata.org/entity/Q41955736

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Outcomes of Gleason Score ≤ 8 ...... rapy based multimodal therapy.

@en

type

Item

label

Outcomes of Gleason Score ≤ 8 ...... rapy based multimodal therapy.

@en

prefLabel

Outcomes of Gleason Score ≤ 8 ...... rapy based multimodal therapy.

@en

P1476

Outcomes of Gleason Score ≤ 8 ...... rapy based multimodal therapy.

@en

P2093

Don Kyung Choi

http://www.w3.org/2001/XMLSchema#string

Dong Soo Park

http://www.w3.org/2001/XMLSchema#string

Hyun Soo Shin

http://www.w3.org/2001/XMLSchema#string

In Hyuck Gong

http://www.w3.org/2001/XMLSchema#string

Jin Ho Hwang

http://www.w3.org/2001/XMLSchema#string

Jong Jin Oh

http://www.w3.org/2001/XMLSchema#string

P2860

Case-matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancer.

Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).

Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64.

What are the outcomes of radical prostatectomy for high-risk prostate cancer?

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy.

Radical prostatectomy for high-risk prostate cancer.

Contemporary treatment of high-risk localized prostate cancer.

The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.

P304

1207-1213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3349/YMJ.2013.54.5.1207

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255690221

http://www.w3.org/2001/XMLSchema#string

P698

23918571

http://www.w3.org/2001/XMLSchema#string

P921

brachytherapy

P932

3743192

http://www.w3.org/2001/XMLSchema#string

Outcomes of Gleason Score ≤ 8 among high risk prostate cancer treated with 125I low dose rate brachytherapy based multimodal therapy.

about

P2860

P2860

Outcomes of Gleason Score ≤ 8 among high risk prostate cancer treated with 125I low dose rate brachytherapy based multimodal therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932